Introduction Semaglutide has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://mpowerdirectory.com/listings521625/semaglutide-a-breakthrough-in-managing-type-2-diabetes-obesity-and-heart-health